Figure 30: Photograph of Professor Sir Stephen Bloom, 2013, credit: Bloom
(Switzerland) Altimmune (US) Glenmark Pharmaceuticals Ltd (India) Biocon (India) Teva Pharmaceuticals (Israel) MARKET SCOPE WHAT IS IN IT FOR YOU: GLP-1 Agonists Market REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS September 2025 : Novo Nordisk (Denmark) received EU approval for its oral GLP-1 receptor agonist drug, Rybelsus, to reduce cardiovascular death, heart attack, and stroke
During better appetite days, whole food protein should come back in
Talk to your healthcare provider about the steps youve taken, such as changes to your diet, weight loss surgery, exercise habits, or behavior, and be honest about what hasnt worked
doi: 10.1210/jc.2008-0115 56 Gonzlez-OrtizMMartnez-AbundisERobles-CervantesJARamos-ZavalaMG
Neuropsychopharmacology (2014) 39:223343